Poland A. & Knutson JC2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annual Review of Pharmacology and Toxicology1982; 22: 517-54.
2.
Sweeney GD, Jones KGCole FM, Basford D. & Krestynski F.Iron deficiency prevents liver toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin . Science1979; 204: 332-5.
3.
Greig JB, Francis JE, Kay Sje, Lovell DP & Smith AGIncomplete correlation of 2,3,7,8-tetrachlorodibenzo-p-dioxin hepatotoxicity with the Ah-phenotype in mice. Toxicology and Applied Pharmacology1984; 74: 17-25.
4.
Smith AG & Francis JESynergism of iron and hexachlorobenzene inhibits hepatic uroporphyrinogen decarboxylase in inbred mice. Biochemical Journal1983; 214: 909-13.
5.
Cantoni L., Dal Fiume D., Rizzardini M. & Ruggieri R.In vitro inhibitory effect on porphyrinogen carboxylase of liver extracts from TCDD treated mice. Toxicology Letters1984; 20: 211-7.
6.
Smith AG & Francis JEChemically-induced formation of an inhibitor of hepatic uroporphyrinogen decarboxylase in inbred mice with iron overload. Biochemical Journal1987; 246: 221-6.
7.
Francis JE & Smith AGOxidation of uroporphyrinogens by hydroxyl radicals. Evidence for nonporphyrin products as potential inhibitors of uroporphyrinogen decarboxylase . FEBS Letters1988; 233: 311-4.
8.
Smith AG, Francis JE, Dinsdale D., Manson MM & Cabral Jrp.Hepatocarcinogenicity of hexachlorobenzene in rats and the sex difference in hepatic iron status and development of porphyria. Carcinogenesis1985; 6: 631-6.